Abdul Salam Khan

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells

A. Österborg, A. Moshfegh, J. Lundin, 2013, PloS one.

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia

P. Kokhaei, A. Österborg, A. Moshfegh, 2016, Tumor Biology.

Application of CAR T cells for the treatment of solid tumors.

R. Brentjens, Abdul Salam Khan, Jonathan F Khan, 2019, Progress in molecular biology and translational science.

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.

A. Osterborg, A. Moshfegh, H. Mellstedt, 2014, Seminars in cancer biology.

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies

A. Österborg, A. Moshfegh, H. Mellstedt, 2015, British journal of haematology.

Ror1 Targeting Monoclonal Antibodies Induced Apoptosis of Chronic Lymphocytic Leukemia Cells– A Potential Novel Therapeutic Approach

M. Jeddi-Tehrani, F. Shokri, H. Mellstedt, 2010 .

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells

M. Jeddi-Tehrani, F. Shokri, A. Österborg, 2012, Leukemia.

Abstract 4770: Anti-ROR1 monoclonal antibodies induce apoptosis in pancreatic cancer cells via the PI3-kinase/AKT/mTOR pathway

A. Österborg, A. Moshfegh, H. Mellstedt, 2014 .

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells

J. Shetye, J. Schultz, P. Kokhaei, 2018, Leukemia.